Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00883844
What this trial is testing

PEG-IFN in HBV Patients With Incomplete Response to NA

Who this might be right for
Chronic Hepatitis B
Foundation for Liver Research 11
Post-approval studies (Phase 4)Study completedNCT00724620
What this trial is testing

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Schering-Plough 103
Early research (Phase 1)Study completedNCT00970996
What this trial is testing

Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 10
Not applicableUnknownNCT04943679
What this trial is testing

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 15
Early research (Phase 1)Study completedNCT02112032
What this trial is testing

Treatment of Advanced Melanoma With MK-3475 and Peginterferon

Who this might be right for
Melanoma
Hassane M. Zarour, MD 43
Large-scale testing (Phase 3)Active Not RecruitingNCT06514807
What this trial is testing

Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 117
Early research (Phase 1)Study completedNCT04638439
What this trial is testing

The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Who this might be right for
Chronic Hepatitis B InfectionChronic Hepatitis D Infection
PharmaEssentia 20
Not applicableUnknownNCT02605252
What this trial is testing

New Strategy Study of Functional Cure of Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University 120
Testing effectiveness (Phase 2)Study completedNCT00135798
What this trial is testing

Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79
Testing effectiveness (Phase 2)Looking for participantsNCT06770842
What this trial is testing

Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
The University of Hong Kong 20
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Large-scale testing (Phase 3)Study completedNCT04382937
What this trial is testing

Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
PharmaEssentia 222
Large-scale testing (Phase 3)Study completedNCT04846491
What this trial is testing

Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 475
Testing effectiveness (Phase 2)Study completedNCT01158534
What this trial is testing

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Renal Cell CancerStage IV Renal Cell Cancer
Case Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT01405937
What this trial is testing

Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 51
Post-approval studies (Phase 4)WithdrawnNCT06290765
What this trial is testing

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

Who this might be right for
Polycythemia VeraMyeloproliferative Neoplasm
PharmaEssentia
Large-scale testing (Phase 3)UnknownNCT00002767
What this trial is testing

Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT03537274
What this trial is testing

Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 1,224
Not applicableEnded earlyNCT00725842
What this trial is testing

Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)

Who this might be right for
Hepatitis CHepatitis C, Chronic
Merck Sharp & Dohme LLC 97
Next Page